Search This Blog

Wednesday, February 12, 2025

Tenet results, outlook

 Tenet’s Outlook for full year 2025 (consolidated and by segment) follows.

CONSOLIDATED ($ in millions, except per share amounts)

FY 2025 Outlook

Net operating revenues

$20,600 to $21,000

Net income available to Tenet common stockholders

$1,040 to $1,185

Adjusted EBITDA

$3,975 to $4,175

Adjusted EBITDA margin

19.3% to 19.9%

Diluted income per common share

$10.95 to $12.47

Adjusted net income

$1,115 to $1,220

Adjusted diluted earnings per share

$11.74 to $12.84

Equity in earnings of unconsolidated affiliates

$265 to $275

Depreciation and amortization

$805 to $835

Interest expense

$795 to $805

Income tax expense5

$420 to $465

Net income available to NCI

$910 to $960

Weighted average diluted common shares

~95 million

Net cash provided by operating activities

$2,500 to $2,850

Adjusted net cash provided by operating activities

$2,600 to $2,900

Capital expenditures

$700 to $800

Free cash flow

$1,800 to $2,050

Adjusted free cash flow

$1,900 to $2,100

NCI cash distributions

$750 to $800

Ambulatory Segment ($ in millions)

FY 2025 Outlook

Net operating revenues

$4,850 to $5,000

Adjusted EBITDA

$1,915 to $1,985

NCI

$760 to $790

Adjusted EBITDA less NCI

$1,155 to $1,195

Changes versus prior year6:

 

Same-facility system-wide revenue

Up 3.0% to 6.0%

 
 

Hospital Segment ($ in millions)

FY 2025 Outlook

Net operating revenues

$15,750 to $16,000

Adjusted EBITDA

$2,060 to $2,190

NCI

$150 to $170

Changes versus prior year6:

 

Inpatient admissions

Up 2.0% to 3.0%

Adjusted admissions

Up 2.0% to 3.0%

Management’s Webcast Discussion of Results

Tenet management will discuss the Company’s fourth quarter 2024 results in a webcast scheduled for 10:00 a.m. Eastern Time (9:00 a.m. Central Time) on February 12, 2025. Investors can access the webcast through the Company’s website at www.tenethealth.com/investors.

The slide presentation associated with the webcast referenced above, a copy of this earnings press release, and a related supplemental financial disclosures document will be available on the Company’s Investor Relations website on February 12, 2025.

https://www.businesswire.com/news/home/20250212977320/en

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.